Friday, 16 October 2026European Markets

MEDIA CAPITAL Stock Went Up By Over 10% So Far On Thursday

Loading stream...

(VIANEWS) - Shares of MEDIA CAPITAL (PSI: MCP.LS) jumped 10% to €1.21 at 13:26 EST on Thursday, after five successive sessions in a row of losses. PSI is jumping 0.83% to €5,978.80, after two successive sessions in a row of losses. This seems, so far, a somewhat positive trend exchanging session today.

About MEDIA CAPITAL

Grupo Media Capital, SGPS, S.A. engages in the production and broadcasting of television and radio programs, and production and operation of cinematographic and video graphic activities in Portugal and internationally. It operates through Television, Radio & Entertainment, Audiovisual Production, and Others segments. The company broadcasts TVI, TVI 24, TVI Ficção, TVI Internacional, TVI Reality, and TVI Player channels. It is involved in the production, realization, and distribution of audiovisuals; and production of television programs for broadcasting in Portuguese language. The company operates Rádio Comercial, m80, Cidade FM, Smooth FM, and Vodafone FM radio stations; and 14 digital radios. It also operates iol.pt, an online directory of classified information; recording, publishing, events production, and artist management; and provides agency services for artists and promotion of events. The company is also involved in the provision of production support services; realization and development of television contents, cinema, and audiovisual works, as well as other related services; production of phonograms, audiovisual, and multimedia; purchase and sale of records and other items; and acquisition and distribution of cinematographic rights. Grupo Media Capital, SGPS, S.A. was incorporated in 1992 and is headquartered in Barcarena, Portugal.

Earnings Per Share

As for profitability, MEDIA CAPITAL has a trailing twelve months EPS of €-0.888.

Volume

Today's last reported volume for MEDIA CAPITAL is 301 which is 73.36% below its average volume of 1130.

More news about MEDIA CAPITAL (MCP.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com